仟源医药: 第五届董事会第三十一次会议决议公告

Group 1 - The company held its 31st meeting of the 5th Board of Directors on August 8, 2025, via telecommunication voting, with all 9 directors present [1] - The board approved the repurchase and cancellation of 60,000 restricted stocks from a departing employee at a price of 4.73 yuan per share, which will also include interest at the bank's term deposit rate [1][2] - The board agreed to change the registered capital and amend the Articles of Association due to the cancellation of the restricted stocks, which will be submitted for approval at the upcoming extraordinary shareholders' meeting [2][3] Group 2 - The board approved the initial grant of restricted stocks under the 2025 incentive plan, with a total of up to 7.95 million shares to be granted at a price of 5.60 yuan per share, effective from August 8, 2025 [3] - The company will hold its 4th extraordinary shareholders' meeting on August 26, 2025, combining on-site and online voting methods [3]